Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • Shopping
  • News
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Florida beach shooting
50M copies sold
Rescued after 24 hrs
China declines to meet
Calls for suspension
Ancient rock carvings
Myers' departure soon?
Charter boat sinks
What is HMPV?
Chinese ship detained
Biondi's epic comeback
Explosive at border
Trump retakes lead
Nvidia CEO on AI
Pregnant powerhouses
Ban on spin serve
New Grammy documentary
Lifeguard shortage
Ciampa in Albany
Emergency summit
CN Shenzhou-16 launch
New AI supercomputers
NATO soldiers injured
2 shot dead, 2 stabbed
Costly desalination
'Cried for two days'
'Greatest father ever'
RU hits base in UKR
Advance to NBA Finals
First 3-way sea drill
Calls Uganda to repeal
Chef attacks home
Fractures ankle
Alleged death threats
Wins Coca-Cola 600
On bereavement list
India files graft case
Bishops chastised
Baseball on the Strip
Visit to asteroid belt
TX firefighter stabbed
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
34,200 results
6don MSN
FDA approves Opvee nasal spray to reverse opioid overdose
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as ...
6d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
WTVF27d
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
scrippsnews on MSN6d
FDA approves new drug to reverse opioid overdose
The FDA approved a new nasal spray to reverse the effects of an opioid overdose. Ready why the application for this drug was ...
drugdeliverybusiness6d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
South Florida Times
3d
New nasal spray to reverse fentanyl, opioid overdoses gets FDA approval
Narcan nasal spray for the treatment of opioid overdoses PHOTO COURTESY OF LAIST.COM VIA STOCK PHOTO WASHINGTON (AP) – U.S.
Lincoln Journal Star21d
Nebraska experts reflect on opioid epidemic following FDA approval Narcan
Weishapl is uncertain just how much good the FDA approval will do for the ongoing opioid crisis. “It’s cool, but unless people get it for free, it’s not going to help,” he said.
6d
Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle
After a more than 4-year battle, Plymouth Meeting biotechnology firm Braeburn Inc. has received FDA approval for its opioid ...
Medscape4d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ... chronic pain in patients requiring a continuous, around-the-clock opioid analgesic. News, July 08, 2010 FDA Clears Liquid-Cooled Fiber for ...
Erie Times-News16d
Access to opioid reversal drug naloxone grows as overdoses soar, you can help save lives
In Pennsylvania, residents have access to free naloxone by mail. Now, with new FDA approval, naloxone nasal spray could be for sale in convenience stores, supermarkets and even online by late ...
6d
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
6d
FDA approves Opvee nasal spray for opioid overdoses
The Food and Drug Administration on Monday approved Opvee, the first prescription nasal spray for opioid overdoses using nalmefene hydrochloride.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics

opioid overdose
Opvee
Food and Drug Administration
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback